Patent 12104174 was granted and assigned to President and Fellows of Harvard College on October, 2024 by the United States Patent and Trademark Office.
Described herein are methods for providing an in vitro intestinal model system, e.g., using primary cells instead of cell lines and/or cancerous cells.